Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration
- PMID: 22042369
- DOI: 10.1007/s10549-011-1844-0
Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration
Abstract
Triggering of Toll-like receptor 4 (TLR4) on tumor cells has been found to promote tumor progression by promoting tumor cell proliferation and survival. So far, however, the effect of TLR4 signaling on tumor metastasis has not been well elucidated. Here, we report that triggering of TLR4 on metastatic breast cancer cells could reciprocally regulate the expression of αvβ3 and the expressions of TPM1 and maspin, and promote αvβ3-mediated adhesion and invasive migration of the cells. In metastatic breast cancer cells, TLR4 signaling increased the expression of integrin αvβ3 by activating NF-κB, resulting in the increased adhesion capacity of tumor cells to the ligand for αvβ3, and the increased polymerization of actin and production of MMP-9 in tumor cells in response to ECM. HoxD3 was required for the up-regulation of αv and β3 expressions by NF-κB. Moreover, TLR4 signaling increased the expression of miR-21 in breast cancer cells by activating NF-κB. Accordingly, the expressions of TPM1 and maspin were decreased at protein level, whereas the transcription activity of these genes was not influenced. Consistent with the promoting effect on αvβ3-mediated adhesion and invasive migration, TLR4 signaling promoted the arrest of metastatic breast cancer cells in circulation and following invasion. The effect of TLR4 signaling could be abrogated by inhibiting NF-κB. These findings suggest that metastatic breast cancer cells could acquire higher metastatic potential due to triggering of TLR4 and activation of NF-κB in the cells, and that both TLR4 and NF-κB could be therapeutic targets for preventing metastasis of breast cancer cells.
Similar articles
-
Cyclin D1b splice variant promotes αvβ3-mediated adhesion and invasive migration of breast cancer cells.Cancer Lett. 2014 Dec 1;355(1):159-67. doi: 10.1016/j.canlet.2014.08.044. Epub 2014 Sep 1. Cancer Lett. 2014. PMID: 25193465
-
Targeting nuclear factor-κB suppresses the negative effect of toll-like receptor 4 signaling on antimetastasis therapy based on targeting αvβ3.Cancer Sci. 2012 Jul;103(7):1319-26. doi: 10.1111/j.1349-7006.2012.02299.x. Epub 2012 May 15. Cancer Sci. 2012. PMID: 22494046 Free PMC article.
-
Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis.Oncogene. 2011 Jul 14;30(28):3174-85. doi: 10.1038/onc.2011.28. Epub 2011 Mar 7. Oncogene. 2011. PMID: 21383699
-
Altered Rho GTPase signaling pathways in breast cancer cells.Breast Cancer Res Treat. 2004 Mar;84(1):43-8. doi: 10.1023/B:BREA.0000018422.02237.f9. Breast Cancer Res Treat. 2004. PMID: 14999153 Review.
-
Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype.Breast Cancer Res Treat. 2013 Jan;137(2):329-36. doi: 10.1007/s10549-012-2351-7. Epub 2012 Dec 8. Breast Cancer Res Treat. 2013. PMID: 23224146 Review.
Cited by
-
Links between Toll-like receptor 4 and breast cancer.Oncoimmunology. 2013 Feb 1;2(2):e22945. doi: 10.4161/onci.22945. Oncoimmunology. 2013. PMID: 23526132 Free PMC article.
-
Pattern recognition receptors in health and diseases.Signal Transduct Target Ther. 2021 Aug 4;6(1):291. doi: 10.1038/s41392-021-00687-0. Signal Transduct Target Ther. 2021. PMID: 34344870 Free PMC article. Review.
-
Toll-like receptor-4 modulation for cancer immunotherapy.Front Immunol. 2014 Jul 25;5:328. doi: 10.3389/fimmu.2014.00328. eCollection 2014. Front Immunol. 2014. PMID: 25120541 Free PMC article. Review. No abstract available.
-
Risk of breast cancer in women with non-lactational mastitis.Sci Rep. 2019 Oct 30;9(1):15587. doi: 10.1038/s41598-019-52046-3. Sci Rep. 2019. PMID: 31666573 Free PMC article.
-
Toll-like receptor 4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women.Onco Targets Ther. 2017 Feb 24;10:1207-1216. doi: 10.2147/OTT.S112165. eCollection 2017. Onco Targets Ther. 2017. PMID: 28280355 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous